Glen Santangelo Analyst PerformanceManaging Director at BarclaysGlen Santangelo is a stock analyst at Barclays focused in the healthcare sector, covering 38 publicly traded companies. Over the past year, Glen Santangelo has issued 122 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Glen Santangelo's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Glen Santangelo's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings136 Last 11 YearsBuy Recommendations67.91% 91 Buy RatingsCompanies Covered38 Unique Companies Ratings Distribution134RatingsDistribution of strong buy, buy, hold, and sell ratings by Glen Santangelo.RatingPercentageCount Strong Buy4.5%6 ratings Buy63.4%85 ratings Hold23.9%32 ratings Sell8.2%11 ratingsOut of 134 total stock ratings issued by Glen Santangelo at Barclays, the majority (63.4%) have been Buy recommendations, followed by 23.9% Hold, 8.2% Sell, and 4.5% Strong Buy.Best & Worst CallsBest Call000.0%XERSJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%WAYFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ57.9% of companies on NASDAQ22 companiesNYSE42.1% of companies on NYSE16 companiesGlen Santangelo, an analyst at Barclays, currently covers 38 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare37 companies97.4%Consumer Discretionary1 company2.6%Glen Santangelo of Barclays specializes in stock coverage within the Healthcare sector, with additional focus on Consumer Discretionary companies.Coverage IndustriesIndustryPercentagePHARMACEUTICALS15 companies39.5%HEALTHCARE PROVIDERS & SERVICES9 companies23.7%HEALTHCARE TECHNOLOGY7 companies18.4%HEALTHCARE EQUIPMENT & SUPPLIES5 companies13.2%BIOTECHNOLOGY1 company2.6%TEXTILES, APPAREL & LUXURY GOODS1 company2.6% Glen Santangelo's Ratings History at Barclays Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsXRAYDENTSPLY SIRONA8/24/2026Boost Price Target$10.92$11.00Underweight$0.0000.00% ROIHIMSHims & Hers Health8/21/2026Lower Price Target$33.28$35.00Overweight$0.0000.00% ROIDOCSDoximity8/21/2026Boost Price Target$25.71$27.00Equal Weight$0.0000.00% ROIGDRXGoodRx8/20/2026Boost Price Target$3.56$4.00Underweight$0.0000.00% ROICTEVClaritev8/20/2026Reiterated Rating$34.71$40.00Overweight$0.0000.00% ROIXERSXeris Biopharma8/20/2026Boost Price Target$8.78$12.00Overweight$0.0000.00% ROIMCKMcKesson8/19/2026Boost Price Target$869.73$1,000.00Overweight$0.0000.00% ROICOLLCollegium Pharmaceutical8/19/2026Lower Price Target$28.50$48.00Overweight$0.0000.00% ROIAMPHAmphastar Pharmaceuticals8/18/2026Boost Price Target$21.52$23.00Equal Weight$0.0000.00% ROIPHATPhathom Pharmaceuticals8/14/2026Lower Price Target$9.58$14.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CAHCardinal Health8/13/2026Boost Price Target$234.19$275.00Overweight$0.0000.00% ROITEVATeva Pharmaceutical Industries8/12/2026Boost Price Target$36.48$42.00Overweight$0.0000.00% ROIIDXXIDEXX Laboratories8/11/2026Lower Price Target$595.76$710.00Overweight$0.0000.00% ROIWAYWaystar8/7/2026Boost Price Target$23.37$27.00Overweight$0.0000.00% ROIHSICHenry Schein8/6/2026Reiterated Rating$89.59$100.00Overweight$0.0000.00% ROIINDVIndivior8/5/2026Lower Price Target$36.50$43.00Overweight$0.0000.00% ROIZTSZoetis7/1/2026Lower Price Target$71.88$85.00Equal Weight$0.0000.00% ROIINDVIndivior6/18/2026Initiated Coverage$37.93$46.00Overweight$0.0000.00% ROIINDVIndivior6/18/2026Initiated Coverage$38.28$46.00Overweight$0.0000.00% ROIHIMSHims & Hers Health6/17/2026Boost Price Target$31.97$39.00Overweight$0.0000.00% ROINVSTEnvista6/11/2026Lower Price Target$24.05$32.00Overweight$0.0000.00% ROICORCencora6/10/2026Lower Price Target$279.15$350.00Overweight$0.0000.00% ROIMCKMcKesson6/10/2026Lower Price Target$791.49$925.00Overweight$0.0000.00% ROIXRAYDENTSPLY SIRONA6/4/2026Lower Price Target$9.75$9.00Underweight$0.0000.00% ROIAMPHAmphastar Pharmaceuticals6/3/2026Lower Price Target$18.45$20.00Equal Weight$0.0000.00% ROIMDLNMedline6/1/2026Lower Price Target$36.56$45.00Overweight$0.0000.00% ROIWAYWaystar5/20/2026Lower Price Target$19.60$25.00Overweight$0.0000.00% ROIAMRXAmneal Pharmaceuticals5/20/2026Boost Price Target$11.81$16.00Overweight$0.0000.00% ROIWAYWaystar5/20/2026Lower Price Target$19.21$25.00Overweight$0.0000.00% ROIVTRSViatris5/19/2026Boost Price Target$16.50$22.00Overweight$0.0000.00% ROIPGNYProgyny5/15/2026Boost Price Target$23.25$27.00Overweight$0.0000.00% ROIPHRPhreesia5/14/2026Reiterated Rating$8.77$10.00Equal Weight$0.0000.00% ROIDOCSDoximity5/14/2026Reiterated Rating$17.94$20.00Equal Weight$0.0000.00% ROIDOCSDoximity5/14/2026Downgrade$18.93$20.00Equal Weight$0.0000.00% ROIPHRPhreesia5/14/2026Downgrade$8.78$10.00Equal Weight$0.0000.00% ROITEVATeva Pharmaceutical Industries5/6/2026Boost Price Target$35.85$40.00Overweight$0.0000.00% ROICTEVClaritev4/24/2026Initiated Coverage$20.34$28.00Overweight$0.0000.00% ROICTEVClaritev4/24/2026Initiated Coverage$23.84$28.00Overweight$0.0000.00% ROIAMPHAmphastar Pharmaceuticals4/8/2026Lower Price Target$20.49$23.00Equal Weight$0.0000.00% ROIPHATPhathom Pharmaceuticals3/27/2026Upgrade$10.79$18.00Overweight$0.0000.00% ROIThe end may be near for these iconic stocks (Ad)Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.Watch Marc Chaikin's free presentation and get his full buy-and-sell list todayTDOCTeladoc Health3/26/2026Lower Price Target$5.57$7.00Equal Weight$0.0000.00% ROIPCRXPacira BioSciences3/26/2026Lower Price Target$23.49$25.00Equal Weight$0.0000.00% ROIVTRSViatris3/24/2026Boost Price Target$13.32$17.00Overweight$0.0000.00% ROIALVOAlvotech3/24/2026Lower Price Target$3.07$4.00Underweight$0.0000.00% ROIPGNYProgyny3/20/2026Lower Price Target$17.93$23.00Overweight$0.0000.00% ROIALGNAlign Technology3/17/2026Upgrade$169.45$200.00Overweight$0.0000.00% ROIHIMSHims & Hers Health3/11/2026Boost Price Target$26.25$29.00Overweight$0.0000.00% ROITALKTalkspace3/9/2026Lower Price Target$5.12$5.25Equal Weight$0.0000.00% ROIALGNAlign Technology2/25/2026Boost Price Target$187.52$200.00Equal Weight$0.0000.00% ROIBHCBausch Health Cos2/25/2026Lower Price Target$6.16$7.00Equal Weight$0.0000.00% ROIHIMSHims & Hers Health2/24/2026Lower Price Target$15.93$25.00Overweight$0.0000.00% ROICAHCardinal Health2/24/2026Boost Price Target$224.83$258.00Overweight$0.0000.00% ROIOGNOrganon & Co.2/24/2026Boost Price Target$7.91$8.00Underweight$0.0000.00% ROIHQYHealthEquity2/19/2026Set Price Target$78.86$108.00$0.0000.00% ROIMCKMcKesson2/18/2026Boost Price Target$946.46$1,050.00Overweight$0.0000.00% ROIHQYHealthEquity2/18/2026Lower Price Target$74.36$110.00Overweight$0.0000.00% ROICORCencora2/13/2026Boost Price Target$351.91$425.00Overweight$0.0000.00% ROIDOCSDoximity2/11/2026Lower Price Target$27.28$38.00Overweight$0.0000.00% ROINVSTEnvista2/11/2026Boost Price Target$29.78$34.00Overweight$0.0000.00% ROIIDXXIDEXX Laboratories2/5/2026Lower Price Target$642.94$800.00Overweight$0.0000.00% ROITEVATeva Pharmaceutical Industries1/30/2026Boost Price Target$33.70$38.00Overweight$0.0000.00% ROIGDRXGoodRx1/22/2026Downgrade$2.58Hold$0.0000.00% ROIGDRXGoodRx1/22/2026Reiterated Rating$2.58$2.75Hold$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$50.00Overweight$0.0000.00% ROICOLLCollegium Pharmaceutical1/9/2026Lower Price Target$47.12$56.00Overweight$0.0000.00% ROITEVATeva Pharmaceutical Industries1/6/2026Boost Price Target$32.12$40.00Buy$0.0000.00% ROIPHRPhreesia12/16/2025Lower Price Target$16.70$24.00Overweight$0.0000.00% ROIASAmer Sports12/9/2025Initiated Coverage$37.23$49.00Overweight$0.0000.00% ROIAMPHAmphastar Pharmaceuticals12/9/2025Initiated Coverage$26.01$30.00Equal Weight$0.0000.00% ROIELANElanco Animal Health12/9/2025Initiated Coverage$21.69$30.00Overweight$0.0000.00% ROIOGNOrganon & Co.12/9/2025Initiated Coverage$7.30$7.50Underweight$0.0000.00% ROIPCRXPacira BioSciences12/9/2025Initiated Coverage$24.42$27.00Equal Weight$0.0000.00% ROITDOCTeladoc Health12/9/2025Initiated Coverage$7.56$8.50Equal Weight$0.0000.00% ROITEVATeva Pharmaceutical Industries12/9/2025Initiated Coverage$28.32$35.00Overweight$0.0000.00% ROIANIPANI Pharmaceuticals12/9/2025Initiated Coverage$82.80$100.00Overweight$0.0000.00% ROIASAmer Sports12/9/2025Initiated Coverage$38.65$49.00Overweight$0.0000.00% ROIZTSZoetis12/8/2025Initiated Coverage$118.09$136.00Equal Weight$0.0000.00% ROIXERSXeris Biopharma12/8/2025Initiated Coverage$6.99$9.00Overweight$0.0000.00% ROIVTRSViatris12/8/2025Initiated Coverage$11.09$15.00Overweight$0.0000.00% ROITARSTarsus Pharmaceuticals12/8/2025Initiated Coverage$82.23$100.00Overweight$0.0000.00% ROIIDXXIDEXX Laboratories12/8/2025Initiated Coverage$706.65$850.00Overweight$0.0000.00% ROICOLLCollegium Pharmaceutical12/8/2025Initiated Coverage$47.91$58.00Overweight$0.0000.00% ROIBHCBausch Health Cos12/8/2025Initiated Coverage$6.84$8.00Equal Weight$0.0000.00% ROIAMRXAmneal Pharmaceuticals12/8/2025Initiated Coverage$11.87$15.00Overweight$0.0000.00% ROIALVOAlvotech12/8/2025Initiated Coverage$5.45$5.00Underweight$0.0000.00% ROITALKTalkspace12/8/2025Initiated Coverage$3.13$3.50Equal Weight$0.0000.00% ROIPHRPhreesia12/8/2025Initiated Coverage$20.28$26.00Overweight$0.0000.00% ROIMCKMcKesson12/8/2025Initiated Coverage$797.42$960.00Overweight$0.0000.00% ROIHSICHenry Schein12/8/2025Initiated Coverage$72.86$86.00Overweight$0.0000.00% ROIGDRXGoodRx12/8/2025Initiated Coverage$2.72$3.00Underweight$0.0000.00% ROIIran War Shock: What I Was Told In That Private Meeting (Ad)You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.Because THIS is the real reason.NVSTEnvista12/8/2025Initiated Coverage$20.00$24.00Overweight$0.0000.00% ROIDOCSDoximity12/8/2025Initiated Coverage$45.77$63.00Overweight$0.0000.00% ROICORCencora12/8/2025Initiated Coverage$337.67$400.00Overweight$0.0000.00% ROICAHCardinal Health12/8/2025Initiated Coverage$198.48$243.00Overweight$0.0000.00% ROIALGNAlign Technology12/8/2025Initiated Coverage$157.68$170.00Equal Weight$0.0000.00% ROIXRAYDENTSPLY SIRONA12/8/2025Initiated Coverage$11.10$12.00Underweight$0.0000.00% ROIHIMSHims & Hers Health12/8/2025Initiated Coverage$39.05$48.00Overweight$0.0000.00% ROIALGNAlign Technology12/8/2025Initiated Coverage$159.00$170.00Equal Weight$0.0000.00% ROIAMPHAmphastar Pharmaceuticals12/8/2025Upgrade$25.65Hold$0.0000.00% ROIAMRXAmneal Pharmaceuticals12/8/2025Initiated Coverage$11.97$15.00Overweight$0.0000.00% ROIBHCBausch Health Cos12/8/2025Initiated Coverage$6.80$8.00Equal Weight$0.0000.00% ROICAHCardinal Health12/8/2025Initiated Coverage$198.01$243.00Overweight$0.0000.00% ROICOLLCollegium Pharmaceutical12/8/2025Initiated Coverage$47.03$58.00Overweight$0.0000.00% ROIDOCSDoximity12/8/2025Initiated Coverage$45.17$63.00Overweight$0.0000.00% ROIELANElanco Animal Health12/8/2025Upgrade$20.45Strong-Buy$0.0000.00% ROIHIMSHims & Hers Health12/8/2025Initiated Coverage$39.67$48.00Overweight$0.0000.00% ROIHSICHenry Schein12/8/2025Initiated Coverage$74.44$86.00Overweight$0.0000.00% ROIIDXXIDEXX Laboratories12/8/2025Initiated Coverage$699.06$850.00Overweight$0.0000.00% ROINVSTEnvista12/8/2025Initiated Coverage$20.61$24.00Overweight$0.0000.00% ROIOGNOrganon & Co.12/8/2025Upgrade$6.93Strong Sell$0.0000.00% ROIPCRXPacira BioSciences12/8/2025Upgrade$24.77Hold$0.0000.00% ROIPHRPhreesia12/8/2025Initiated Coverage$15.46$26.00Overweight$0.0000.00% ROITDOCTeladoc Health12/8/2025Upgrade$7.73Hold$0.0000.00% ROITEVATeva Pharmaceutical Industries12/8/2025Upgrade$28.56Strong-Buy$0.0000.00% ROIVTRSViatris12/8/2025Initiated Coverage$11.19$15.00Overweight$0.0000.00% ROIXERSXeris Biopharma12/8/2025Initiated Coverage$7.01$9.00Overweight$0.0000.00% ROIXRAYDENTSPLY SIRONA12/8/2025Initiated Coverage$11.11$12.00Underweight$0.0000.00% ROICORCencora12/8/2025Upgrade$340.63Strong-Buy$0.0000.00% ROIHQYHealthEquity12/8/2025Upgrade$95.73Strong-Buy$0.0000.00% ROIMCKMcKesson12/8/2025Upgrade$813.74Strong-Buy$0.0000.00% ROITARSTarsus Pharmaceuticals12/8/2025Upgrade$81.32Strong-Buy$0.0000.00% ROIHQYHealthEquity9/3/2025Boost Price Target$93.90$134.00Buy$0.0000.00% ROITDOCTeladoc Health4/21/2025Lower Price Target$6.45$8.00Hold$0.0000.00% ROIANIPANI Pharmaceuticals3/14/2025Initiated Coverage$61.46$80.00Buy$00.0000.00% ROIVTRSViatris3/7/2025Lower Price Target$9.58$13.00Buy$00.0000.00% ROIWAYWaystar2/11/2025Initiated Coverage$41.45$51.00Buy$00.0000.00% ROIXERSXeris Biopharma1/29/2025Reiterated Rating$3.66$6.00Buy$0.0000.00% ROIXRAYDENTSPLY SIRONA1/23/2025Downgrade$19.36$20.00Hold$00.0000.00% ROINVSTEnvista1/23/2025Boost Price Target$21.18$22.00Hold$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
